Comparison
NMN vs Pomegranate Extract
NMN
Nicotinamide mononucleotide — NAD+ precursor. Studied for cellular aging and metabolic health.
Pomegranate Extract
Standardised extract rich in punicalagins. Cardiovascular and cognitive benefits; metabolised to urolithins by gut bacteria.
| Field | NMN | Pomegranate Extract |
|---|---|---|
| Category | neuroprotective | neuroprotective |
| Dose range | 250–1000mg | 250–1000mg |
| Half-life | — | — |
| Onset | — | — |
| Evidence | EVIDENCEB | EVIDENCEB |
| Safety | ●●●●● | ●●●●● |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 600 | 1200 |
The comparison in plain English
Auto-generated from dataNMN and Pomegranate Extract are both in the neuroprotective category respectively. NMN Nicotinamide mononucleotide — NAD+ precursor. Pomegranate Extract Standardised extract rich in punicalagins.
Bottom line
NMN (evidence B, safety 5/5) matches the evidence base of Pomegranate Extract (evidence B, safety 5/5). NMN has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose NMN if
NMN is the better fit when your goal aligns with its mechanism (Direct precursor to NAD+ — one biosynthetic step closer than nicotinamide riboside, bypassing the NRK1/NRK2 enzymatic step) and the dose range (250–1000mg) suits your protocol. Half-life is —h.
Choose Pomegranate Extract if
Pomegranate Extract is the better fit when your goal aligns with its mechanism (Punicalagins and other ellagitannins are metabolised by gut bacteria to urolithin A and related compounds) and the dose range (250–1000mg) suits your protocol. Half-life is —h.